AI-Powered Biomedical
Intelligence Platform
Six precision-engineered applications spanning drug safety, molecular visualization, protein simulation, pharmacokinetics, genomics, and clinical research — built to serve Malaysia's healthcare and research sectors.
// Developed in Penang, Malaysia · Powered by xAI Grok
Drug Safety, Molecular Science
& Protein Simulation
Three flagship AI tools for pharmaceutical research, structural biology, and drug interaction analysis — each powered by xAI Grok and deployable across iOS, macOS, and Windows.
Detects dangerous drug combinations, classifies severity from minor to life-threatening, and delivers pharmacological explanations — designed for pharmacists, clinical educators, and safety-conscious practitioners.
Visualize proteins in real-time 3D using RCSB Protein Data Bank structures or custom PDB files. Grok AI predicts binding affinity, free energy calculations, and molecular interactions for pharmaceutical research workflows.
Integrates SMILES parsing with AI-powered pharmaceutical analysis for researchers, medicinal chemists, and STEM educators — bridging chemical structure to drug-likeness prediction in a single workflow.
Transform RNA-seq data into publication-ready insights. Import DESeq2/edgeR CSVs to generate interactive volcano plots and heatmaps, with pathway enrichment narrated by Grok AI.
Professional pharmacokinetic modeling for calculating half-life, clearance, and volume of distribution with AI-assisted dosing simulations. Built for clinical pharmacology and pharmaceutical development workflows.
Real-time tracking of Phase I–IV trials worldwide. AI-summarized outcomes, adverse event classification, and recruitment criteria for researchers and clinicians managing complex trial portfolios.
Unified Biomedical AI Platform
Across Research & Clinical Domains
EGK BioMedic Series is a cohesive AI-powered biomedical ecosystem — spanning drug safety, molecular modeling, protein simulation, genomics, and clinical intelligence.
EGK BioMedic applications are designed for educational and research purposes only. They are not certified medical devices and must not be used for clinical decision-making, patient diagnosis, or treatment planning without validation by qualified healthcare professionals. All AI outputs are computational estimates subject to expert review.
Government & WHO
Collaboration Roadmap
EGK BioMedic Series is positioned as a secure AI biomedical computation layer — built to partner with Kementerian Kesihatan Malaysia (KKM) and the World Health Organization on three foundational pillars.
- Data sandbox access (NOT raw production systems)
- Retrospective anonymised datasets (5–10 years)
- Pilot hospital collaboration (1–2 hospitals initially)
- De-identified clinical outcomes & drug adverse events
- Access to global health datasets
- Participation in pilot digital health programs
- Alignment endorsement with WHO AI guidelines
"We request access to anonymised datasets for AI model validation under a controlled research sandbox — EGK can operationalise WHO datasets into actionable AI systems."
Reality Check: We will NOT request live patient data or direct EMR access. We start with historical + anonymised datasets only. Keyword: sandbox — it reduces institutional risk perception.
- Joint validation studies (UM, UKM, USM clinical researchers)
- Ethics board (IRB) approval support & pathway guidance
- Co-authored publications for mutual academic credibility
- Benchmark datasets for model performance comparison
- AI governance frameworks & ethical AI standards
- Endorsement of specific pilot use cases
- Alignment with WHO Digital Health Strategy 2020–2025
"EGK provides the AI system; clinicians validate the outcomes. You don't need to be the AI developer — we don't need to be the doctor. We build the layer between."
Key Insight: WHO will not validate our product directly — but their AI governance endorsement and pilot use case alignment is sufficient to build institutional credibility with Malaysian hospitals and MOH.
- FHIR / HL7 compliance documentation & developer access
- Sandbox API access to hospital system endpoints
- Integration pilot with 1 hospital + 1 insurance provider
- MySejahtera / national health ID interoperability guidance
- Anonymised claims datasets from pilot insurers
- Drug usage patterns for coverage intelligence
- Fraud / anomaly data for detection model training
- Creates a Clinical + Financial AI loop — extremely powerful
"Standard protocols (FHIR/HL7) + sandbox access to 1 hospital + 1 insurer = a fully demonstrable Clinical-Financial AI loop that no other Malaysian AI company has built."
The Language That Opens Institutional Doors
Government and hospital partners respond to specific language. We never say "I want to use patient data." We present EGK as a secure AI biomedical computation layer operating within existing regulatory and ethical frameworks — enhancing decision support, never replacing clinicians.
EGK provides a secure AI biomedical
computation layer that:
• Processes anonymised clinical data
• Enhances decision support
(not replacing doctors)
• Operates within regulatory and
ethical frameworks
• Integrates via standard protocols
(FHIR / HL7)
• PDPA 2010 compliant by design
Introducing EGK AIInsure
AI-Powered Health Insurance
EGK is launching Malaysia's first AI-native health insurance platform — purpose-built to integrate with BioMedic Series clinical data flows. Autonomous claims processing, real-time underwriting, and fraud detection powered by Mushi AI, with full BNM compliance and PDPA 2010 data sovereignty.
The Clinical–Financial AI Loop
EGK AIInsure connects directly to BioMedic Series data outputs — creating a closed-loop AI system spanning clinical intelligence and insurance decisioning.